Abiopharma

JCDecaux : Disclosure of transactions in own shares

JCDecaux : Déclaration des transactions sur actions propres

NEURONES: Declaration of transactions on treasury shares (June 8 to 12, 2026)

NEURONES : Déclaration des transactions sur actions propres (période du 8 au 12 juin 2026)

Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy

Correction: Ekstraordinære indfrielser (CK 93)

Ekstraordinære indfrielser (CK 93)

Net Asset Value(s)

RBLX Investors Have Opportunity to Lead Roblox Corporation Securities Fraud Lawsuit with the Schall Law Firm

Northern Trust Receives Approval for New EU Banking Branch in Ireland